|
1
|
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.
|
Blood
|
2008
|
4.66
|
|
2
|
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).
|
Blood
|
2002
|
1.85
|
|
3
|
Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
|
Leuk Lymphoma
|
2008
|
1.53
|
|
4
|
Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML.
|
Blood
|
2011
|
1.17
|
|
5
|
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.
|
Cancer
|
2011
|
0.99
|
|
6
|
Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q.
|
Eur J Haematol
|
2013
|
0.93
|
|
7
|
Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry.
|
Am J Hematol
|
2015
|
0.91
|
|
8
|
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study.
|
Br J Haematol
|
2003
|
0.89
|
|
9
|
The effect of ciprofloxacin on cyclophosphamide pharmacokinetics in patients with non-Hodgkin lymphoma.
|
Eur J Haematol
|
2005
|
0.77
|
|
10
|
Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia.
|
Ther Drug Monit
|
2007
|
0.77
|
|
11
|
Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.
|
Eur J Haematol
|
2014
|
0.75
|